Syncromune, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2020-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.syncromune.com
A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer
Phase 2
Recruiting
- Conditions
- Metastatic Castration-resistant Prostate Cancer
- Interventions
- Procedure: Partial Oncolysis
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Syncromune, Inc.
- Target Recruit Count
- 70
- Registration Number
- NCT06533644
- Locations
- 🇺🇸
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
🇺🇸Michigan Institute of Urology, Troy, Michigan, United States
🇺🇸Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, United States
© Copyright 2025. All Rights Reserved by MedPath